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A report on the Cologne Spring Meeting ‘Immunity’,
Cologne, Germany, 13-15 March 2002.
The Cologne Spring Meeting organized by the Institute for
Genetics in Cologne covers a different topic each year. This
year’s meeting on the theme ‘Immunity’ consisted of 22 talks
over two and a half days. The meeting dealt with all aspects
of immunity, ranging from cell-autonomous immunity,
which functions in all nucleated cells, to the adaptive
immune system that depends on B and T cells. It is becom-
ing increasingly clear that the immune system has many
layers, all of which are essential and highly interconnected.
Here, I summarize some representative talks on different
aspects of immunity. 
Memory
Antonio Lanzavecchia (Institute of Biomedicine, Bellinzona,
Switzerland) addressed the question of how memory is main-
tained in the adaptive immune system. In particular, he
focused on the role of cytokines derived from dendritic cells
(DCs) - tumor necrosis factor (TNF) , interleukin (IL)-6,
IL-10 and IL-12 - in promoting the proliferation of CD4+
T cells in response to c cytokines, which bind to receptors
that share the  common (c) signaling chain, namely IL-2,
IL-4, IL-7 and IL-15. Lanzavecchia reported that sensitivity to
cytokines, and expression of cytokine receptors, vary with the
differentiation stage of T cells. Naïve human CD4+ T cells
progressively acquire responsiveness to IL-7 and IL-15 and
upregulate the IL-2/IL-15 receptor  chain while differentiat-
ing to central memory T (TCM) cells or effector memory T
(TEM) cells. In addition, IL-7 and IL-15 act synergistically on
all T-cell sub-populations but only TEM can directly prolifer-
ate in response to these cytokines. In contrast, naïve and TCM
cells also need DCs or DC-derived cytokines in order to
upregulate their relevant receptors. Lanzavecchia empha-
sized the striking difference in the response of naïve T cells
and TCM to cytokine stimulation. Cytokine-expanded naïve
T cells maintain a lymph-node homing phenotype
(CD45RA+, CCR7+) and undergo only limited differentiation.
In contrast, TCM cells acquire a phenotype resembling that
of TEM cells by downregulating CCR7 and upregulating
CCR5 cytokine receptors. Like TEM cells, these cells produced
high levels of interferon (IFN)  and IL-4, indicating that
TCM populations can generate cells resembling TEM cells in
an antigen-independent manner. 
Lanzavecchia proposed a model according to which TCM
cells not only self-renew but also generate short-lived TEM
cells. These TEM cells leave the secondary lymphoid organs
and reside in peripheral tissue, where they can immediately
respond to antigen. This would give the TCM population a
stem-cell-like character, constantly replenishing the pool of
short-lived peripheral TEM cells, and would explain how a
polyclonal repertoire of memory T cells is maintained. Lan-
zavecchia also briefly presented a model and supporting
evidence for long-term antibody memory based on chronic
nonspecific stimulation of memory B cells by bacterial
products such as lipopolysaccharide (LPS). This model puts
the principles of T- and B-cell memory maintenance on the
same basis.
Autoimmunity
Diane Mathis (Harvard Medical School, Boston, USA) pre-
sented fascinating work on a mouse model of rheumatoid
arthritis. Characteristic of this autoimmune disease is the
specific destruction of the synovial joints caused by local
inflammation and recruitment of neutrophils and
macrophages. B and T cells are essential for development of
the disease, although their exact role remains controversial.
Furthermore, what causes the recruitment of inflammatory
cells in this apparently joint-specific manner is unknown.
Working with K/BxN mice, which are the product of mice
transgenic for a T-cell receptor (TCR) known as KRN
crossed to the spontaneous autoimmune diabetic mouse,
Mathis and colleagues observed development of severe,
spontaneous rheumatoid arthritis. It was subsequentlyshown that the KRN TCR recognizes a peptide derived from
the ubiquitously expressed glycolytic enzyme glucose-6-
phosphate isomerase (GPI) when it is presented by major
histocompatibility complex (MHC) class II molecules. T and
B cells autoreactive against GPI are essential for manifesta-
tion of the autoimmune disorder. Astonishingly, however,
transfer of either serum from arthritic K/BxN mice or anti-
GPI monoclonal antibodies into healthy animals provokes
arthritis within days, even when the recipients are devoid of
lymphocytes. Using serum transfer into various knockout
mice, Mathis and colleagues investigated the cause of the
joint-specific inflammation by a ubiquitously expressed
enzyme and which factors are involved in the attraction of
inflammatory cells. They found that mice lacking the FcRI,
FcRIII and FcRIII immunoglobulin (Ig) receptors were
completely resistant to induction of rheumatoid arthritis by
injection of serum from arthritic K/BxN mice. She also
showed that the complement system is an essential player in
the progression to rheumatoid arthritis in these mice. Sur-
prisingly, the ‘alternative’ pathway of complement activa-
tion, which is normally activated by bacterial surfaces, seems
to be the critical initiating route, resulting in the formation
of C5a, the proinflammatory product of cleaving comple-
ment protein C5, and in turn recruitment of leukocytes and
in particular neutrophils to the joints.
Having established the important roles of FcR and the
complement system in the development of rheumatoid
arthritis, Mathis asked why an autoimmune reaction to GPI
should result in specific inflammation of the articular
surface of the joints. No joint-specific form of GPI was
found, so the regional specificity of the disease must result
from something else. Mathis found that GPI is somehow
localized on joint surfaces and that it co-localizes there with
IgG and also - in a conjunction unique to this site - with the
complement component C3. This may mean that GPI-IgG
complexes also form in extra-articular organs but that they
do not initiate a complement cascade there. Mathis sug-
gested that the reason for the joint localization and cascade
initiation is the lack of complement inhibitory factors on the
joint surface, which, unlike other organ surfaces, does not
have an outer cellular layer. 
Finally, Mathis proposed a model for initiation and progres-
sion of rheumatoid arthritis in K/BxN mice. First, necrotic
cells release GPI, which circulates in minute amounts in the
bloodstream but accumulates on the joint surface, probably
as a result of low-affinity interactions with carbohydrate
chains of the cartilage extracellular matrix. Next, autoreac-
tive B cells internalize complexes between B-cell receptors
and GPI, and present them on MHC class II molecules to
KRN-transgenic T cells. In turn, these T cells stimulate the
presenting B cells to produce high levels of anti-GPI IgGs.
These IgGs bind to GPI on the joint surface, forming large
complexes leading to the activation of the complement
system. The complement component C5a functions together
with the Fc unit of the autoreactive IgGs to recruit and acti-
vate leukocytes and, in particular, neutrophils. These cells
eventually invade the joints, resulting in the destruction
characteristic of rheumatoid arthritis. It will be interesting
to see how this revolutionary revision of the established
wisdom - namely that rheumatoid arthritis is a T-cell-
mediated disease - will stand up in the human case. 
Innate immunity
A large part of the meeting was devoted to innate immunity.
In recent years most attention has been focused on cell-
surface receptors from the Toll-like receptor (TLR) family
(presented at the meeting by Jules Hoffmann, Institut de
Biologie Moléculaire et Cellulaire, Strasbourg, France and
Bruce Beutler, Scripps Research Institute, La Jolla, USA).
These proteins are structurally similar to Toll, which is an
important receptor involved in natural immunity in
Drosophila. They are now seen as a family that provide the
main recognition sites on many, perhaps most cell surfaces
for many products that characterize pathogens (for example,
surface LPS, peptidoglycan, flagellin, unmethylated CpG-
DNA, and double-stranded RNA). Stimulation of these
receptors ultimately leads to activation of the whole pro-
gramme of immunity. 
A highlight was the talk given by Gabriel Nuñez (University
of Michigan, Ann Arbor, USA) about a family of cytosolic
receptors called Nods. Several members of this family have
been found in mammals. They are related to a class of plant
resistance genes (R genes) that confer resistance to
pathogens by inducing several defense programs, such as
alterations of host-cell metabolism or cell death. The R genes
contain an amino-terminal Toll-IL-1-receptor domain (TIR),
a central nucleotide-binding domain (NBD) and a carboxy-
terminal domain containing multiple leucine-rich repeats
(LRRs). Recently, Nuñez and colleagues identified in
mammals several proteins with a similar domain architec-
ture containing the central NBD or NOD (nucleotide-
binding oligomerization domain) and the amino-terminal
LRR domain, but bearing amino-terminal caspase-recruit-
ment domains (CARD) instead of the TIR domain. Two of
them, namely Nod1 and Nod2, were most surprisingly
shown to behave as cytosolic receptors for bacterial prod-
ucts. Whereas the expression of Nod2 is restricted to mono-
cytes, Nod1 is expressed ubiquitously in adult tissue.
Activation by bacterial LPS in the case of Nod1 and Nod2
and by bacterial peptidoglycan in the case of Nod2 leads to
activation of NFB (nuclear factor B) and subsequent tran-
scription of target genes. 
Nuñez showed that the LRR domains are essential for LPS
responsiveness, because truncated proteins lacking the
LRRs do not mediate LPS-induced activation of NFB. He
presented a model according to which the recognition of
LPS (or other unknown activators) by Nods leads to
2 Genome Biology Vol 3 No 8  Martensself-oligomerization and recruitment of RICK, a CARD con-
taining serine/threonine kinase, via CARD-CARD interac-
tion. Subsequently RICK activates NFB in a way that is
dependent on IB (inhibitor B) manner. Nuñez reported
that, interestingly, this pathway is independent of MyD88
and TRAF6, two essential components of TLR4 signaling. So
the TLRs as well as the Nods are receptors sensing
pathogen-associated molecular patterns in different envi-
ronments. They initiate different signaling pathways that
merge at the level of NFB activation. 
A frameshift mutation and two point mutations in Nod2 are
associated with Crohn’s disease, a chronic inflammation of
the gut. The frameshift results in a truncated protein that
lacks a part of the last LRR of Nod2 and abolishes respon-
siveness to LPS. Nuñez speculated that lack of Nod2 signal-
ing in monocytes leads to the inability to control enteric
bacteria, abnormal T-cell responses and eventually inflam-
mation. He reported that there are over 30 Nod homologs in
the human genome, yielding the fascinating possibility that,
like the TLRs, these proteins build an intracellular surveil-
lance system for pathogen-associated molecular patterns. 
Gene silencing
Just a few years ago a new system was discovered that can
protect animals and plants from RNA viruses and trans-
posons. Several terms, such as RNA interference (RNAi),
post-transcriptional gene silencing (PTGS), quelling and
cosuppression have been used to describe basically the same
protection phenomenon. David Baulcombe (The Sainsbury
Laboratory, Norwich, UK) presented some fascinating work
conducted to reveal the mechanism by which this system
works. (I will accept Baulcombe’s proposal and generally
refer to this phenomenon as gene silencing.) Gene silencing
has many features of the adaptive immune system in verte-
brates in that it is highly specific, systemic and confers a
degree of memory. Strikingly, it seems to be present in all
eukaryotes from fungi, plants and invertebrates to verte-
brates, including mammals. The fact that, at least in plants,
certain viruses produce factors interfering with gene silenc-
ing underlines the importance of this system in immunity.
Baulcombe and colleagues used Arabidopsis thaliana as a
model to dissect certain steps involved in the initiation and
systemic spread of gene silencing. Plants expressing a green
fluorescent protein (GFP) transgene under a constitutive
promoter turned out to be particularly useful for this
purpose, because systemic spreading of gene silencing could
be easily assessed by silencing of GFP fluorescence through-
out the plant. By means of either viral infection or delivery of
a second transgene by Agrobacterium transformation,
Baulcombe was able to analyze which genes are involved in
transgene- or virus-induced gene silencing. At least two
pathways are involved. The first is initiated by transgenes
generating single-stranded RNA transcripts that depend on
SDE1, an RNA-dependent-RNA-polymerase (RdRP), and
SDE3, an RNA helicase that converts single-stranded RNA
into double-stranded RNA. In contrast, virus-induced gene
silencing is SDE1- and SDE3-independent, because the virus
brings its own RdRP. 
It was remarkable to see how the exploitation of genomic
data contributes to the revelation of fundamental principles
of immunity throughout eukaryotes as well as to the discov-
ery of differences between and even within species. For
example, the same gene silencing mechanisms and receptors
for pathogen-associated molecular patterns containing NBD,
TIR, CARD and/or LRR domains are present in both plants
and mammals. But Peter Parham (Stanford University
School of Medicine, USA) emphasized that there are sub-
stantial differences in the natural killer (NK) cell receptor
repertoire even between humans and chimpanzees, although
their genomes are estimated to be about 98.8% identical.
Stephen O’Brien (National Cancer Institute, Frederick, USA)
reported that variations in a single gene can have a huge
impact on the control of HIV infection and progression to
AIDS: 26% of rapid progressors and 20% of long-term sur-
vivors bear certain chemokine receptor, killer immunoglob-
ulin-like receptor or HLA alleles, and such people have a
difference in life span of up to ten years or more. 
It is becoming strikingly clear that immunity is conferred by
many, highly interconnected layers of recognition and effec-
tor systems. New essential players are being discovered all
the time. A good example is a family of GTP-binding pro-
teins, the so-called p47 GTPases, whose indispensable role
in mice in providing resistance against intracellular protozoa
and bacteria was discovered only in the past two years (pre-
sented by Greg Taylor, Duke University, Durham, USA).
This complexity, which is common and vital to eukaryotic
life, is also reflected on the genomic level and it will be fasci-
nating to see how large the proportion of the genome that is
involved in fighting pathogens ultimately proves to be;
recent experiments on macrophages have already implicated
25% of the genome in playing this role.
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